1. Home
  2. FRSX vs SXTP Comparison

FRSX vs SXTP Comparison

Compare FRSX & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.87

Market Cap

4.9M

Sector

Technology

ML Signal

HOLD

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$1.71

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSX
SXTP
Founded
N/A
2010
Country
Israel
United States
Employees
N/A
3
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
FRSX
SXTP
Price
$1.87
$1.71
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.10
AVG Volume (30 Days)
1.6M
74.7K
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$33.92
Revenue Next Year
N/A
$51.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.34
52 Week High
$3.00
$8.62

Technical Indicators

Market Signals
Indicator
FRSX
SXTP
Relative Strength Index (RSI) 53.61 62.15
Support Level $1.24 $1.29
Resistance Level $1.90 $1.82
Average True Range (ATR) 0.16 0.15
MACD 0.04 0.03
Stochastic Oscillator 73.33 70.18

Price Performance

Historical Comparison
FRSX
SXTP

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

Share on Social Networks: